WOONSOCKET, R.I., Sept. 3, 2019 /PRNewswire/ -- Five years after it made the bold move to pull tobacc

CHICAGO, Sept. 3, 2019 /PRNewswire/ -- September is Dental Implant Awareness Month, sponsored by the American Academy of Implant Dentistry (AAID). This year's theme, "What's your reason to smile?" focuses on the many ways dental implants can have a life-changing impact.

MARLBOROUGH, Mass., Sept. 3, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform, announced today that it will present at the H.C. Wainwright 21st Annual Healthcare Conference

PITTSBURGH, Sept. 3, 2019 /PRNewswire/ -- ANSYS (NASDAQ: ANSS) is collaborating with

TORONTO, Sept. 3, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (US:TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new hybrid greenhouse located in

ROCKVILLE, Md., Sept. 3, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, U.S., and throughout the world, announces it will present at the 2019 H.C. Wainwright 21st Annual Global Investmen

JERUSALEM, Sept. 3, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences in September.HC Wainwright 21st Annual Global Investment ConferenceDate: September 8-10, 2

TEL AVIV, Israel, Sept. 3, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that it has successfully completed the dose-escalation part of the Phase 1/2a clinical study for AGI-134, a novel compound that evokes a direct anti-tumor response, as well as a vaccine effect, via a u

BINGHAM FARMS, Mich., Sept. 3, 2019 /PRNewswire/ -- The Kahn Center for Cardiac Longevity led by

WARSAW, Ind., Sept. 3, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2019.